The effect of acute kainic acid treatment on μ-opioid receptors in rat brain

Brain Research

Volumn 814, Issue 1-2, 1998, Pages 26-33

  Ridd, Michael J ^a   Fosbraey, Paul ^b   Kitchen, Ian ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b CBD Porton Down   (United Kingdom)

Author keywords

3H DAMGO; Excitotoxin; Neurotoxicity

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAINIC ACID; MU OPIATE RECEPTOR; PRODYNORPHIN; PROENKEPHALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; GRANULE CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LIGAND BINDING; MOSSY FIBER; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR AFFINITY;

ANIMALS; BRAIN; KAINIC ACID; LINEAR MODELS; MALE; NERVE DEGENERATION; NEUROTOXINS; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU;

EID: 0032517753     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00992-5     Document Type: Article

References (36)

1. Ben-Ari Y., Tremblay E., Ottersen O.P. Injections of kainic acid into the amygdaloid complex of the rat: an electrographic, clinical and histological study in relation to the pathology of epilepsy. Neuroscience. 5:1980;515-528.
2. Douglass J., Grimes L., Shook J., Lee P.H.K., Hong J.-S. Systemic administration of kainic acid differentially regulates the levels of prodynorphin and proenkephalin mRNA and peptide in the rat hippocampus. Mol. Brain Res. 9:1991;79-86.
3. Filipkowski R.K., Hetman M., Kaminska B., Kaczmarek L. DNA fragmentation in rat brain after intraperitoneal administration of kainic acid. NeuroReport. 5:1994;1538-1540.
4. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain-I. J. Neurochem. 13:1966;655-669.
5. Harrison M.B., Shumate M.D., Lothman E.W. Opioid peptide expression in models of chronic temporal lobe epilepsy. Neuroscience. 65:1995;785-795.
6. Kellstein D.E., Coghill R.C., Frenk H., Bossut D.F., Mayer D.J. Opioid inhibition of kainic acid-induced scratching: mediation by μ and σ but not δ and K receptors. Pharmacol. Biochem. Behav. 35:1990;1-5.
7. Kim H.C., Suh H.W., Bronstein D., Bing G., Wilson B., Hong J.S. Dextromethorphan blocks opioid peptide gene expression in the rat hippocampus induced by kainic acid. Neuropeptides. 31:1997;105-112.
8. Kleinrok Z., Turski L. Kainic acid-induced wet dog shakes in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 314:1980;37-46.
9. Lason W., Przewlocka B., Stala L., Przewlocki R. Changes in hippocampal immunoreactive dynorphin and neoendorphin content following intra-amygdalar kainic acid-induced seizures. Neuropeptides. 3:1983;399-404.
10. Lason W., Przewlocka B., Van-Luijtelaar G., Coenen A. Proenkephalin and prodynorphin mRNA level in brain of rats with absence epilepsy. Neuropeptides. 27:1994;343-347.
11. Lason W., Lason P.R. Seizure-induced expression of G proteins in the rat hippocampus. Mol. Brain Res. 24:1994;65-69.
12. Lason W., Simpson J.N., McGinty J.F. μ but not δ opioid receptor stimulation intensifies kainic acid-induced neurotoxicity in rat hippocampus. Neuropeptides. 12:1988;89-94.
13. Lason W., Simpson J.W., McGinty J.F. The interaction between κ-opioid agonist, U-50,488H, and kainic acid: behavioural and histopathological assessments. Brain Res. 482:1989;333-339.
14. Lee P.H.K., Obie J., Hong J.-S. Opioids induce convulsions and wet dog shakes in rats: mediation by hippocampal μ, but not δ or K opioid receptors. J. Neurosci. 9:1989;692-697.
15. Lenicque P.M., Wepierre J., Cohen Y. The role of monoamines in the behavioural effects of kainic acid in rats. J. Neural. Trans. 51:1981;205-212.
16. Lothman E.W., Collins R.C., Ferrendelli J.A. Kainic-acid induced limbic seizures: electrophysiological studies. Neurology. 31:1981;806-812.
17. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
18. Lu Y.M., Lu B.F., Yan Y.L., Ho X.P., Wang W.J. Alterations of G-protein coupling function in phosphoinositide signalling pathways of rat hippocampus by ischaemic brain injury. Eur. J. Neurosci. 5:1993;1334-1338.
19. Mansour A., Khaxhaturian H., Lewis M.E., Akil H., Watson S.J. Autoradiographic differentiation of μ, δ and K opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7:1987;2445-2464.
20. 3H ]-kainic acid binding sites in rat CNS as determined by autoradiography Brain Res. 252:1982;91-100.
21. Nadler J.V. Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci. 29:1981;2031-2042.
22. Olney J.W., Fuller T., De Gubareff T. Acute dendrotoxic changes in the hippocampus of kainate-treated rats. Brain Res. 176:1979;91-100.
23. 3H ]kainic acid and binding sites in the rat brain: in vivo and in vitro receptor autoradiography Neurosci. Lett. 70:1986;301-307.
24. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
25. Perry D.C., Grimes L.M. Administration of KA and colchinine alters μ and λ binding in rat hippocampus. Brain Res. 477:1989;100-108.
26. Przewlocki R., Kaminska B., Lukasiuk K., Nowicka D.Z., Przewlocka B., Kaczmarek L., Lason W. Seizure regulated changes in the regulation of opioid genes and transcription factors in the dentate gyrus of rat hippocampus. Neuroscience. 68:1995;73-81.
27. 2 receptors in rat brain. Neurosci. Res. 30:1998;201-211.
28. Robson L.E., Gillan M.G.C., Kosterlitz H.W. Species differences in the concentrations and distributions of opioid binding sites. Eur. J. Pharmacol. 112:1985;65-71.
29. Schwob J.E., Fuller T., Price J.L., Olney J.W. Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience. 5:1980;991-1014.
30. Sloviter R.S., Damiano B.P. On the relationship between kainic acid-induced epileptiform activity and hippocampal neuronal damage. J. Neuropharmacol. 20:1981;1003-1011.
31. Sperk G., Berger M., Horntnagl H., Hornykiewicz O. Kainic acid-induced seizures of 5-HT and dopamine metabolism in the striatum and substantia nigra of the rat. Eur. J. Pharmacol. 74:1981;279-286.
32. Sperk G., Lassmann H., Baran H., Kish S.J., Seitelberger F., Hornykiewicz O. Kainic acid-induced seizures: neurochemical and histopathological changes. Neuroscience. 10:1983;1301-1315.
33. Suyama K., Saito K., Chen G., Bai-Shen P., Manji H.K., Potter W.Z. Alterations in cyclic AMP generation and G protein subunits following transient ischemia in gerbil hippocampus. J. Cereb. Blood Flow Metab. 15:1995;877-885.
34. Tortella F.C., Robles L., Mosberg H.T. Evidence for μ opioid receptor mediation of enkephalin-induced electroephalographic seizures. J. Pharmacol. Exp. Ther. 240:1987;571-577.
35. Yeadon M., Kitchen I. Comparative binding of μ and δ selective ligands in whole brain and pons/medulla homogenates from rat: affinity profiles of fentanyl derivatives. Neuropharmacology. 27:1988;345-348.
36. Zaczek R., Coyle J.T. Excitatory amino acid analogues: neurotoxicity and seizures. Neuropharmacology. 21:1981;15-26.